New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off

Melanotan 2 (MT2)

From $50.00

Shop

Melanotan 2 (MT2) · Research brief

How Much Melatonin Per Day? Daily Dose Guide

43 WORDS

Short answer

A 2023 analysis published in JAMA found that over 60% of melatonin supplements sold contain doses 2–10 times higher than what clinical evidence supports for most sleep disturbances. And in some cases, actual melatonin content varied by more than 450% from labeled amounts.

Key takeaways

  • The standard adult dose for sleep-onset insomnia is 0.5–2mg taken 30–60 minutes before bedtime. Clinical trials show no additional benefit from doses above 3mg for most people.
  • Melatonin acts as a chronobiotic signal to the suprachiasmatic nucleus, not a sedative. Once MT1 and MT2 receptors are saturated (typically at 0.3–1mg), higher doses don't increase effectiveness.
  • Formulation type significantly affects bioavailability: sublingual and liquid forms deliver 2–3 times higher plasma levels than oral tablets at the same nominal dose.
  • Extended-release formulations are more effective for sleep-maintenance insomnia than immediate-release because they maintain therapeutic levels for 6–8 hours instead of clearing within 4 hours.
  • Doses above 5mg are rarely justified for general insomnia and increase the risk of next-day grogginess, vivid dreams, and suppression of endogenous melatonin production.
  • Adults over 55 typically need lower doses (0.5–1mg) than younger adults due to reduced melatonin clearance and metabolism, not higher doses as commonly assumed.

A 2023 analysis published in JAMA found that over 60% of melatonin supplements sold contain doses 2–10 times higher than what clinical evidence supports for most sleep disturbances. And in some cases, actual melatonin content varied by more than 450% from labeled amounts. The supplement industry has normalized 5mg and 10mg doses as standard when physiological research consistently shows most adults respond optimally to 0.3–2mg.

We've worked with hundreds of researchers investigating circadian biology and peptide signaling pathways. The gap between what the market sells and what the science shows comes down to three things: formulation misconceptions, a misunderstanding of melatonin's mechanism as a chronobiotic rather than a sedative, and the fact that higher doses don't equate to better outcomes. They often produce the opposite effect.

How much melatonin per day should adults take for sleep?

Most adults achieve optimal sleep-onset support with 0.5–3mg of melatonin taken 30–60 minutes before bedtime. Clinical trials consistently show that doses above 5mg do not improve sleep latency or duration compared to lower doses and may cause next-day grogginess, vivid dreams, or disrupted natural melatonin production. The effective dose depends on the specific sleep issue being addressed. Sleep-onset insomnia responds to lower doses (0.3–1mg) while circadian phase disorders like jet lag may require 3–5mg for short-term use.

The common assumption is that melatonin works like a traditional sedative. More dose equals stronger effect. That's not how melatonin functions. It's a chronobiotic hormone that signals the suprachiasmatic nucleus in the hypothalamus to initiate the biological transition to sleep. Taking 10mg doesn't make that signal 10 times stronger; it saturates receptors without additional benefit and can blunt your body's endogenous melatonin production over time. This article covers the physiological mechanisms that determine optimal dosing, how age and formulation type alter requirements, what dosing errors most people make without realizing it, and when higher doses are actually warranted versus when they're counterproductive.

The Physiological Mechanism That Determines Your Optimal Melatonin Dose

Melatonin doesn't induce sleep through sedation. It acts on MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN), the brain's master circadian clock, to signal that darkness has arrived and sleep should begin. MT1 receptor activation suppresses neuronal firing in the SCN, which decreases wakefulness-promoting signals. MT2 receptor activation phase-shifts the circadian rhythm itself, adjusting when your body expects to sleep. These receptors follow saturation kinetics. Meaning they reach maximum activation at relatively low melatonin concentrations, typically 0.3–1mg in most adults.

Once receptors are saturated, additional melatonin doesn't increase the signal strength. It just remains in circulation longer, which is why high doses often cause morning grogginess. Your endogenous melatonin production peaks at approximately 60–120 picograms per milliliter during the night. A 0.5mg oral dose raises plasma melatonin to physiological nighttime levels; a 3mg dose can raise it to 10–20 times normal peak levels. Research from MIT (published in Sleep Medicine Reviews) found that 0.3mg was as effective as 3mg for reducing sleep latency in older adults. The higher dose didn't improve outcomes but did increase next-day residual effects.

Age matters significantly. Adults over 55 produce roughly 50% less endogenous melatonin than younger adults, which is why lower supplemental doses (0.5–1mg) often restore normal sleep architecture without overshooting physiological levels. Children and adolescents, conversely, produce high endogenous melatonin and rarely need supplementation unless addressing specific circadian disorders like delayed sleep phase syndrome. In which case 0.5–1mg is typically sufficient.

How Formulation Type Changes the Melatonin Per Day Daily Dose You Actually Need

Immediate-release melatonin reaches peak plasma concentration within 30–60 minutes and clears within 4–6 hours, making it effective for sleep-onset insomnia but less useful for sleep-maintenance insomnia. Extended-release formulations mimic the body's natural melatonin curve by releasing an initial dose followed by sustained release over 6–8 hours, maintaining therapeutic levels throughout the night. A standard 3mg extended-release tablet delivers a lower effective peak concentration than a 3mg immediate-release tablet but maintains therapeutic levels longer.

Sublingual and liquid formulations bypass first-pass hepatic metabolism, meaning they deliver higher bioavailability at lower nominal doses. A 1mg sublingual melatonin lozenge produces plasma levels comparable to a 3mg oral tablet because it's absorbed directly through the mucosa into systemic circulation. This is why sublingual dosing typically starts at 0.3–1mg rather than 3–5mg. Transdermal patches deliver even lower doses (0.1–0.5mg) continuously across 8–10 hours, producing the steadiest plasma curve with minimal peak-trough variation.

For sleep-onset issues. Difficulty falling asleep. Immediate-release at 0.5–2mg works best. For sleep-maintenance issues. Waking during the night. Extended-release at 2–3mg or a split-dose protocol (1mg immediate + 1mg extended) often proves more effective than a single high dose. The formulation determines how much melatonin per day daily dose you need because it changes both bioavailability and duration of action.

When Higher Melatonin Doses Are Warranted — and When They're Counterproductive

Certain clinical scenarios justify doses above the standard 0.5–3mg range. Jet lag across multiple time zones may require 3–5mg taken at the destination bedtime for 3–5 nights to accelerate circadian realignment. The dose is higher because you're actively phase-shifting your biological clock, not just promoting sleep onset. Shift work sleep disorder, particularly rotating shifts, may benefit from 3–5mg doses timed to the desired sleep period to override conflicting circadian signals from irregular light exposure.

Delayed sleep phase syndrome (DSPS), common in adolescents and young adults, sometimes requires 3–5mg taken 4–6 hours before desired bedtime to advance the circadian phase. But this should be done under medical supervision because mistimed dosing can worsen the phase delay. REM sleep behavior disorder, a parasomnia where patients physically act out dreams, shows response to higher doses (3–12mg) in some cases, though this is off-label use and requires prescriber oversight.

Here's where most people go wrong: taking 5–10mg nightly for general insomnia without a specific circadian disorder. Clinical evidence shows this doesn't improve sleep quality compared to lower doses and increases the risk of next-day cognitive impairment, rebound insomnia upon discontinuation, and suppression of endogenous melatonin production. A 2022 systematic review in the Journal of Clinical Sleep Medicine found no additional benefit for doses above 2mg in adults with primary insomnia. Higher doses increased adverse effects without improving sleep latency, total sleep time, or sleep efficiency.

The bottom line: unless you're addressing a circadian phase disorder or working with a prescriber on a specific parasomnia protocol, doses above 3mg are rarely justified and often counterproductive.

How Much Melatonin Per Day Daily Dose: Comparison

Sleep Issue Recommended Dose Range Timing Before Bed Formulation Type Bottom Line
Sleep-onset insomnia (difficulty falling asleep) 0.5–2mg 30–60 minutes Immediate-release Lower doses (0.5–1mg) are often as effective as higher doses. Start low and increase only if needed after 3–5 nights
Sleep-maintenance insomnia (waking during night) 2–3mg 60 minutes Extended-release or split-dose Sustained-release formulations outperform immediate-release for mid-night awakenings. Single high-dose immediate-release doesn't address the issue
Jet lag (crossing 3+ time zones) 3–5mg At destination bedtime Immediate-release Short-term use only (3–5 nights). Higher dose justified to accelerate circadian phase shift, not for long-term nightly use
Shift work sleep disorder 3–5mg Before desired sleep period Immediate-release Timing matters more than dose. Take at consistent time relative to sleep window, not clock time
Age 55+ with reduced endogenous production 0.5–1mg 30–60 minutes Immediate-release or extended-release Older adults often need lower doses than younger adults due to reduced metabolism and clearance
Children/adolescents (circadian disorders only) 0.3–1mg 60–90 minutes Immediate-release Should be used under medical supervision. Not for general sleep hygiene issues, only diagnosed circadian disorders like DSPS

What If: Melatonin Dosing Scenarios

What If I've Been Taking 10mg Nightly for Months — Should I Stop Abruptly?

Taper gradually over 2–3 weeks rather than stopping abruptly. Drop to 5mg for 5–7 nights, then 3mg for 5–7 nights, then 1mg for 5–7 nights before discontinuing. Abrupt cessation after long-term high-dose use can cause rebound insomnia for 3–7 nights as your endogenous production restarts. The taper allows your pineal gland to resume normal melatonin synthesis without a sudden gap in signaling to the SCN.

What If I Take Melatonin But Still Wake Up at 3 AM Every Night?

Switch from immediate-release to extended-release or use a split-dose protocol. 1mg immediate-release at bedtime plus 1mg extended-release. Sleep-maintenance insomnia (mid-night awakenings) occurs when melatonin levels drop too early in the sleep cycle. Immediate-release clears plasma within 4 hours, so if you fall asleep at 11 PM, levels are subtherapeutic by 3 AM. Extended-release maintains levels for 6–8 hours, covering the full sleep period.

What If I Feel Groggy Every Morning After Taking Melatonin?

Reduce your dose. You're likely overshooting receptor saturation and experiencing residual sedation from excess circulating melatonin. Try cutting your current dose in half for 3–5 nights. If you're taking 5mg, drop to 2.5mg. If you're taking 3mg, try 1mg. Morning grogginess typically indicates the dose exceeds what your body needs to signal sleep onset, and the excess remains active into the early morning hours when you should be transitioning to wakefulness.

The Blunt Truth About Melatonin Dosing

Here's the honest answer: the supplement industry has convinced people that melatonin is a sleep drug when it's actually a darkness signal. The 5mg and 10mg gummies lining pharmacy shelves aren't evidence-based doses. They're marketing decisions designed to create a perception of potency. Clinical research consistently shows that doses above 2mg provide no additional benefit for most sleep disturbances and often produce worse outcomes: next-day impairment, tolerance development, and suppression of your body's own melatonin production.

The disconnect exists because melatonin is sold as a dietary supplement, not a medication. Meaning manufacturers aren't required to demonstrate efficacy or optimize dosing. A 2017 study in the Journal of Clinical Sleep Medicine tested 31 commercial melatonin supplements and found actual melatonin content ranged from −83% to +478% of the labeled amount. You might be taking 10mg when the bottle says 3mg, or 1mg when it says 5mg. And you wouldn't know the difference because there's no regulatory oversight requiring potency verification.

If you're taking melatonin nightly at doses above 3mg without a diagnosed circadian disorder, you're likely overshooting physiological need without improving sleep quality. Start at 0.5–1mg for 5 nights. If that doesn't reduce sleep latency, increase to 2mg. If 2mg doesn't work after a week, the issue isn't dose. It's either timing, formulation type, or an underlying sleep disorder that melatonin won't address.

Melatonin supplementation doesn't work for everyone. Fewer than half of adults with primary insomnia experience clinically meaningful improvement from melatonin regardless of dose. Lower doses simply carry fewer risks when they don't work. The goal isn't to knock yourself out. It's to provide the signal your brain needs to initiate the sleep process at the right time.

For researchers exploring peptide signaling pathways and circadian regulation at a mechanistic level, our collection of research-grade compounds includes tools for investigating melatonin receptor pharmacology, SCN signaling cascades, and chronobiotic mechanisms beyond what commercial supplements can address. Every peptide we provide undergoes third-party verification for purity and exact amino acid sequencing. Because when you're studying biological mechanisms at the molecular level, dosing precision and compound integrity aren't optional.

The relationship between melatonin dose and sleep quality is nonlinear, receptor-mediated, and highly individual. The right dose for most people is far lower than what the market normalizes. And understanding why that's true matters more than memorizing a number.

Questions

Start with 0.5–1mg of immediate-release melatonin taken 30–60 minutes before your desired bedtime. Clinical trials show that doses in this range are as effective as higher doses for reducing sleep latency in most adults and carry the lowest risk of next-day grogginess or tolerance development. If you see no improvement after 5–7 nights at 1mg, increase to 2mg — but there’s no evidence that starting at 5mg or 10mg improves outcomes compared to titrating from a lower dose.
Short-term use (up to 3 months) at physiological doses (0.5–3mg) is well-tolerated in most adults, but long-term nightly use — particularly at doses above 3mg — may suppress endogenous melatonin production and cause tolerance, requiring progressively higher doses to maintain the same effect. Research on safety beyond 6 months of continuous use is limited. If you need melatonin nightly for extended periods, work with a prescriber to identify and address the underlying cause of the sleep disturbance rather than relying on indefinite supplementation.
Clinical evidence shows that 1mg and 10mg produce nearly identical improvements in sleep latency and total sleep time because melatonin receptors saturate at low doses — once MT1 and MT2 receptors in the SCN are activated, additional melatonin doesn’t amplify the signal. The difference is that 10mg produces plasma levels 20–30 times higher than physiological nighttime levels, which increases the likelihood of next-day sedation, vivid dreams, and rebound insomnia when discontinued. The 10mg dose doesn’t work better — it just stays in your system longer and causes more side effects.
Melatonin is regulated as a dietary supplement, not a medication, so manufacturers aren’t required to demonstrate efficacy or use evidence-based dosing — they can sell any dose they choose without clinical justification. Higher doses create a perception of potency and allow companies to charge more, even though research consistently shows that 0.5–2mg is optimal for most sleep issues. A 2017 analysis found that melatonin content in commercial supplements varied from −83% to +478% of labeled amounts, meaning a 10mg tablet might contain 3mg or 50mg — there’s no regulatory oversight requiring accuracy.
No — the mechanism and dosing are different. For jet lag, melatonin functions as a circadian phase-shifting agent: taking 3–5mg at your destination bedtime for 3–5 nights actively resets your biological clock to the new time zone by signaling the SCN to advance or delay your circadian rhythm. For general insomnia without a phase disorder, melatonin acts as a sleep-onset signal at much lower doses (0.5–2mg) without shifting your overall circadian timing. Jet lag dosing is short-term and deliberately higher to accelerate phase adjustment — using those doses long-term for everyday sleep is unnecessary and increases side effect risk.
For sleep-onset insomnia, take melatonin 30–60 minutes before your desired bedtime — this aligns with the natural rise in endogenous melatonin that occurs 1–2 hours before sleep. For circadian phase disorders like delayed sleep phase syndrome, timing shifts earlier: taking melatonin 4–6 hours before your current sleep time can gradually advance your circadian rhythm over several weeks. Taking melatonin too early (more than 2 hours before bed for general insomnia) may not improve sleep latency, and taking it too late (less than 30 minutes before bed) may not reach peak plasma levels before you attempt to sleep.
No — children and adolescents produce significantly higher endogenous melatonin than adults and typically need lower doses (0.3–1mg) when supplementation is medically warranted. Melatonin use in children should be limited to diagnosed circadian disorders like delayed sleep phase syndrome or sleep disturbances related to neurodevelopmental conditions such as ADHD or autism spectrum disorder — it’s not appropriate for general bedtime resistance or behavioral sleep issues. Pediatric dosing should always be supervised by a healthcare provider because inappropriate use can disrupt normal circadian development.
Melatonin doesn’t cause physical dependence in the way benzodiazepines or other sedatives do, but psychological dependence and tolerance can develop — meaning you may feel unable to sleep without it even though your body is physiologically capable of producing its own melatonin. Long-term high-dose use (above 3mg nightly for months) may suppress the pineal gland’s endogenous production through negative feedback, requiring a taper period when discontinuing. The risk is lower with physiological doses (0.5–2mg) used intermittently rather than nightly for extended periods.
Yes — melatonin is metabolized by CYP1A2 enzymes in the liver, so drugs that inhibit this pathway (fluvoxamine, ciprofloxacin, certain antidepressants) can increase melatonin plasma levels and amplify sedative effects. Melatonin may also enhance the effects of other sedatives, anticoagulants like warfarin, immunosuppressants, and antihypertensive medications. If you’re taking prescription medications, particularly those affecting the central nervous system or metabolism, consult your prescriber before starting melatonin to avoid adverse interactions or unintended dose amplification.
Sublingual melatonin delivers higher bioavailability at lower nominal doses because it bypasses first-pass hepatic metabolism — a 1mg sublingual dose produces plasma levels comparable to a 3mg oral tablet. This makes sublingual forms more efficient for achieving therapeutic levels without excess circulating melatonin, but ‘more effective’ depends on the specific sleep issue: immediate absorption may benefit sleep-onset insomnia, while extended-release oral tablets may work better for sleep-maintenance issues. The key is matching formulation to the mechanism you’re trying to address.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now